Searched for
SYSTEMATIX GROUP
Slowing rural incomes could weigh on consumer demand: Dhananjay SinhaHeadline rural wage growth in India is misleading, with underlying increases significantly lower than reported. Rising inflation, reverse m...- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Suzlon Energy shares jump 3%: Why brokers see up to 36% upside for ‘most investible Indian wind player’Suzlon Energy shares rose 3% after management unveiled an ambitious FY31 growth roadmap at its Investor Day. The company plans to evolve fr...
- Inflation and input costs threaten earnings momentum going forward: Dhananjay SinhaIndia Inc. delivered strong March-quarter earnings, surpassing market forecasts. Revenue growth improved, supported by cost savings. Howeve...
- IT stocks see tactical rotation as banking fatigue triggers sector shift: Dhananjay SinhaThe Indian IT sector's recent interest is seen as tactical, not structural, as banking stocks show fatigue. Rising crude oil prices are dri...
- Don't go all in right now; Systematix bets on PSU banks, IT, and defence, avoids realty and jewelleryGeopolitical tensions necessitate a disciplined, diversified investment approach, according to Systematix Group's Nikhil Khandelwal. He adv...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- EM is back, India is next: Why the 2025 underperformance is the perfect setup for a 2026 comebackEmerging Markets led global returns in 2025, but India lagged due to outflows and weaker earnings. With valuations correcting and domestic ...
- Pharma stocks buck market weakness as Dr Reddy's gainsPharma stocks showed strength on Thursday, defying market weakness. Dr Reddy's Laboratories saw significant gains, fueled by anticipation o...
- El Niño and geopolitical tensions cloud India’s rural economy: A somber 2026 outlookIndia’s rural economy faces pressure in 2026 from a likely El Niño-driven weak monsoon and rising input costs due to US-Iran tensions. Lowe...
- Semaglutide API price plunges amid GLP-1 rushGlobal demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapi...
- Pharma calls in sick after Trump’s 100% tariff threatPharma stocks fell Thursday after reports of US President Donald Trump mulling 100% tariffs on imported branded and patented medicine maker...
- ETMarkets Smart Talk | From liquidity to earnings: Why 2026 will be a stock-picker’s market, Nikhil Khandelwal decodesIndian equities enter 2026 on a mature footing, shifting from liquidity-driven gains to an earnings-focused environment. Investors must pri...
- US FDA review boosts odds for Wockhardt’s NCE success story: Vishal ManchandaWockhardt’s breakthrough respiratory drug Zaynich moves a step closer to market as the US FDA accepts it for review, boosting approval odds...
- Domestic demand to drive markets as global trade momentum slows: Dhananjay SinhaIndia Inc's optimism for the second half of FY26 is tempered by muted Q2 earnings, with companies focusing on cost control. While markets a...
- Expect sector rotation ahead; investors must stay nimble: Dhananjay SinhaDhananjay Sinha of Systematix Group suggests a cautious market outlook. Upcoming results season, tariff concerns, and US Fed rate decisions...
- Will vibrancy in domestic pharma market sustain? Vishal Manchanda answersSo I would say US has started to move on a positive trajectory. Earlier it was on a declining trajectory and a cause of concern for most co...
- Downgrades drag Divi's Laboratories to 2-year lowShares of the Hyderabad-based pharmaceutical ingredient company closed at ₹3,297 apiece on the NSE. The stock touched an intraday low of ₹3...
- 4 sectors that will outperform over next 12 to 15 months: Vipul Sanghvi“One large sector continues to be banks and the entire BFSI space. Second, the entire industrial and capital goods basket, which is facing ...
- LEAP India raises $13 mln in Series B fundingThe company plans to invest the funds to strengthen its team and enhance technology to differentiate and deliver best in class services to ...
Load More
